Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1347587
PUBLISHER: IMARC | PRODUCT CODE: 1347587
Cancer Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
PUBLISHED:
PAGES: 149 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Market Overview:
The global cancer vaccines market size reached US$ 6.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 12.1 Billion by 2028, exhibiting a growth rate (CAGR) of 11.61% during 2023-2028.
Cancer is a malignant tumor caused by the uncontrollable growth of abnormal cells in the body. It can be treated through the use of various medications and vaccines. Between these, vaccines are broadly categorized into preventive and therapeutic. Preventive cancer vaccines are deployed for eliminating cancer caused by oncovirus and protecting from human papillomavirus (HPV), whereas therapeutic vaccines aid in stimulating the individual adaptive immune systems by using tumor antigens. At present, cancer vaccines are commercially available in varying types, such as antigen, dendritic cell, and anti-idiotype.
Cancer Vaccines Market Trends:
The increasing prevalence of cancer, especially due to the rising consumption of tobacco-based products and evolving lifestyles is currently driving the cancer vaccines market growth. In line with this, favorable initiatives undertaken by the government bodies of several nations for introducing novel cancer vaccines, along with extensive fundings in the field of viral recombinant cancer vaccines are further facilitating the widespread adoption of these vaccines in the healthcare sector. In line with this, the extensive utilization of United States Food and Drug Administration (US FDA) approved vaccines, including human papillomavirus vaccine (HPV) and hepatitis B vaccine (HBV) to reduce the risk of certain types of cancer, such as liver cancer, is contributing to the market growth. The market is also significantly driven by rapid technological advancements focusing on the development of effective and specific cancer treatments. Other factors, such as improving healthcare infrastructure, rising geriatric population, who are susceptible to various chronic ailments, including cancer, and growing consumer awareness regarding the symptoms and the available treatment options, are creating a positive outlook for the market further across the globe.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global cancer vaccines market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, technology, indication and end user.
Breakup by Type:
Preventive Cancer Vaccines
Therapeutic Cancer Vaccines
Breakup by Technology:
Dendritic Cells Cancer Vaccines
Recombinant Cancer Vaccines
Antigen/Adjuvant Cancer Vaccines
Viral Vector and DNA Cancer Vaccines
Whole-cell Cancer Vaccines
Breakup by Indication:
Cervical Cancer
Prostate Cancer
Others
Breakup by End User:
Pediatrics
Adults
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Anixa Biosciences Inc., Dendreon Pharmaceuticals LLC, Dynavax Technologies Corporation, GSK plc, Merck & Co. Inc., Moderna Inc., OSE Immunotherapeutics, Providence Therapeutics, Sanofi S.A., UbiVac Inc. and Vaccitech plc.
Key Questions Answered in This Report:
- How has the global cancer vaccines market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global cancer vaccines market?
- What are the key regional markets?
- What is the breakup of the market based on the type?
- What is the breakup of the market based on the technology?
- What is the breakup of the market based on the indication?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global cancer vaccines market and who are the key players?
- What is the degree of competition in the industry?
Product Code: SR112023A5901
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Cancer Vaccines Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Type
- 6.1 Preventive Cancer Vaccines
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Therapeutic Cancer Vaccines
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by Technology
- 7.1 Dendritic Cells Cancer Vaccines
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Recombinant Cancer Vaccines
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Antigen/Adjuvant Cancer Vaccines
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Viral Vector and DNA Cancer Vaccines
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Whole-cell Cancer Vaccines
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
8 Market Breakup by Indication
- 8.1 Cervical Cancer
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Prostate Cancer
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Others
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by End User
- 9.1 Pediatrics
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Adults
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.1.1 United States
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.2.1 China
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.3.1 Germany
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.4.1 Brazil
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Anixa Biosciences Inc.
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.1.3 Financials
- 15.3.2 Dendreon Pharmaceuticals LLC
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.3 Dynavax Technologies Corporation
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 Financials
- 15.3.4 GSK plc
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.4.3 Financials
- 15.3.4.4 SWOT Analysis
- 15.3.5 Merck & Co. Inc.
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.5.3 Financials
- 15.3.5.4 SWOT Analysis
- 15.3.6 Moderna Inc.
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.6.3 Financials
- 15.3.7 OSE Immunotherapeutics
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.7.3 Financials
- 15.3.8 Providence Therapeutics
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.9 Sanofi S.A.
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.9.3 Financials
- 15.3.9.4 SWOT Analysis
- 15.3.10 UbiVac Inc.
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.11 Vaccitech plc
- 15.3.11.1 Company Overview
- 15.3.11.2 Product Portfolio
- 15.3.11.3 Financials
- 15.3.1 Anixa Biosciences Inc.
Product Code: SR112023A5901
List of Figures
- Figure 1: Global: Cancer Vaccines Market: Major Drivers and Challenges
- Figure 2: Global: Cancer Vaccines Market: Sales Value (in Billion US$), 2017-2022
- Figure 3: Global: Cancer Vaccines Market Forecast: Sales Value (in Billion US$), 2023-2028
- Figure 4: Global: Cancer Vaccines Market: Breakup by Type (in %), 2022
- Figure 5: Global: Cancer Vaccines Market: Breakup by Technology (in %), 2022
- Figure 6: Global: Cancer Vaccines Market: Breakup by Indication (in %), 2022
- Figure 7: Global: Cancer Vaccines Market: Breakup by End User (in %), 2022
- Figure 8: Global: Cancer Vaccines Market: Breakup by Region (in %), 2022
- Figure 9: Global: Cancer Vaccines (Preventive Cancer Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 10: Global: Cancer Vaccines (Preventive Cancer Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 11: Global: Cancer Vaccines (Therapeutic Cancer Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 12: Global: Cancer Vaccines (Therapeutic Cancer Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 13: Global: Cancer Vaccines (Dendritic Cells Cancer Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 14: Global: Cancer Vaccines (Dendritic Cells Cancer Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 15: Global: Cancer Vaccines (Recombinant Cancer Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 16: Global: Cancer Vaccines (Recombinant Cancer Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 17: Global: Cancer Vaccines (Antigen/Adjuvant Cancer Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 18: Global: Cancer Vaccines (Antigen/Adjuvant Cancer Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 19: Global: Cancer Vaccines (Viral Vector and DNA Cancer Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 20: Global: Cancer Vaccines (Viral Vector and DNA Cancer Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 21: Global: Cancer Vaccines (Whole-cell Cancer Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 22: Global: Cancer Vaccines (Whole-cell Cancer Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 23: Global: Cancer Vaccines (Cervical Cancer) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 24: Global: Cancer Vaccines (Cervical Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 25: Global: Cancer Vaccines (Prostate Cancer) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 26: Global: Cancer Vaccines (Prostate Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 27: Global: Cancer Vaccines (Other Indications) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 28: Global: Cancer Vaccines (Other Indications) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 29: Global: Cancer Vaccines (Pediatrics) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 30: Global: Cancer Vaccines (Pediatrics) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 31: Global: Cancer Vaccines (Adults) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 32: Global: Cancer Vaccines (Adults) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 33: North America: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
- Figure 34: North America: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 35: United States: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
- Figure 36: United States: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 37: Canada: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
- Figure 38: Canada: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 39: Asia-Pacific: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
- Figure 40: Asia-Pacific: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 41: China: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
- Figure 42: China: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 43: Japan: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
- Figure 44: Japan: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 45: India: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
- Figure 46: India: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 47: South Korea: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
- Figure 48: South Korea: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 49: Australia: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
- Figure 50: Australia: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 51: Indonesia: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
- Figure 52: Indonesia: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 53: Others: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
- Figure 54: Others: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 55: Europe: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
- Figure 56: Europe: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 57: Germany: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
- Figure 58: Germany: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 59: France: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
- Figure 60: France: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 61: United Kingdom: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
- Figure 62: United Kingdom: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 63: Italy: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
- Figure 64: Italy: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 65: Spain: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
- Figure 66: Spain: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 67: Russia: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
- Figure 68: Russia: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 69: Others: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
- Figure 70: Others: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 71: Latin America: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
- Figure 72: Latin America: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 73: Brazil: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
- Figure 74: Brazil: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 75: Mexico: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
- Figure 76: Mexico: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 77: Others: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
- Figure 78: Others: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 79: Middle East and Africa: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
- Figure 80: Middle East and Africa: Cancer Vaccines Market: Breakup by Country (in %), 2022
- Figure 81: Middle East and Africa: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 82: Global: Cancer Vaccines Industry: SWOT Analysis
- Figure 83: Global: Cancer Vaccines Industry: Value Chain Analysis
- Figure 84: Global: Cancer Vaccines Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Cancer Vaccines Market: Key Industry Highlights, 2022 and 2028
- Table 2: Global: Cancer Vaccines Market Forecast: Breakup by Type (in Million US$), 2023-2028
- Table 3: Global: Cancer Vaccines Market Forecast: Breakup by Technology (in Million US$), 2023-2028
- Table 4: Global: Cancer Vaccines Market Forecast: Breakup by Indication (in Million US$), 2023-2028
- Table 5: Global: Cancer Vaccines Market Forecast: Breakup by End User (in Million US$), 2023-2028
- Table 6: Global: Cancer Vaccines Market Forecast: Breakup by Region (in Million US$), 2023-2028
- Table 7: Global: Cancer Vaccines Market: Competitive Structure
- Table 8: Global: Cancer Vaccines Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.